Concepedia

Tarsem Moudgil

TM

Statistics

Publications

7

Citations

721

H-Index

7

Active since

1994

Affiliations

Providence Portland Medical Center(Current)

Oregon Health & Science University

Cancer Research Center

UbiVac (United States)

Loyola University Medical Center

Tarsem Moudgil is an author at Providence Portland Medical Center specializing in immunology, oncology, and medicine.

Publications per year

1994–2021

7

Publications

7

OX40 Is a Potent Immune-Stimulating Target in Late-Stage Cancer Patients

Brendan D. Curti, Magdalena Kovacsovics-Bankowski, Nicholas P. Morris et al. · Cancer Research · 2013 · 509 citations

, , +15

Multispectral imaging of formalin-fixed tissue predicts ability to generate tumor-infiltrating lymphocytes from melanoma

Zipei Feng, Sachin Puri, Tarsem Moudgil et al. · Journal for ImmunoTherapy of Cancer · 2015 · 125 citations · Full text

, , +17

All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study.

Parkash S. Gill, Byron M. Espina, Tarsem Moudgil et al. · PubMed · 1994 · 30 citations

, , +8

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts

Sonja Althammer, Keith E. Steele, Marlon C. Rebelatto et al. · Journal for ImmunoTherapy of Cancer · 2016 · 17 citations · Full text

, , +17

A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancer

Rachel E. Sanborn, Helen J. Ross, Sandra Aung et al. · Journal for ImmunoTherapy of Cancer · 2017 · 16 citations · Full text

, , +17

1–5 of 7